Dr. Reddy's Laboratories Limited (RDY)

NYSE: RDY · IEX Real-Time Price · USD

76.12

+0.71 (0.94%)

At close: Jul 2, 2024, 4:00 PM

76.08

-0.04 (-0.05%)

After-hours: Jul 2, 2024, 7:49 PM EDT

Dr. Reddy's Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Year	2023	2022	2021	2020	2019	2018 - 2000
Net Income	55,684	45,067	23,568	17,238	19,498	Upgrade
Depreciation & Amortization	14,841	12,636	11,824	12,796	12,472	Upgrade
Share-Based Compensation	407	397	592	584	521	Upgrade
Other Operating Activities	-25,499	775	-7,876	5,085	-2,650	Upgrade
Operating Cash Flow	45,433	58,875	28,108	35,703	29,841	Upgrade
Operating Cash Flow Growth	-22.83%	109.46%	-21.27%	19.64%	3.96%	Upgrade
Capital Expenditures	-26,371	-18,784	-18,679	-9,656	-4,715	Upgrade
Acquisitions	433	0	-326	-15,514	392	Upgrade
Change in Investments	-14,366	-22,589	-10,328	5,330	410	Upgrade
Other Investing Activities	21	-	2,946	-2,820	-1,010	Upgrade
Investing Cash Flow	-40,283	-41,373	-26,387	-22,660	-4,923	Upgrade
Dividends Paid	-6,648	-4,979	-4,146	-4,147	-3,916	Upgrade
Share Issuance / Repurchase	805	368	334	-924	-470	Upgrade
Debt Issued / Paid	4,346	-20,397	2,735	6,094	-19,165	Upgrade
Other Financing Activities	-2,266	-1,853	-1,345	-1,321	-1,608	Upgrade
Financing Cash Flow	-3,763	-26,861	-2,422	-298	-25,159	Upgrade
Exchange Rate Effect	-59	286	733	113	-25	Upgrade
Net Cash Flow	1,387	-9,359	-701	12,745	-241	Upgrade
Free Cash Flow	19,062	40,091	9,429	26,047	25,126	Upgrade
Free Cash Flow Growth	-52.45%	325.19%	-63.80%	3.67%	9.18%	Upgrade
Free Cash Flow Margin	6.83%	16.31%	4.40%	13.73%	14.39%	Upgrade
Free Cash Flow Per Share	114.47	240.89	56.70	156.75	151.30	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).